Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Vor Bio granted inducement awards to six new employees, consisting of options to purchase 53,400 shares and RSUs representing 11,350 shares. The awards were approved under Nasdaq Rule 5635(c)(4) with a ten-year term and an exercise price of $13.85, matching the closing price on the grant date.
Key figures
- Drug Name
- telitacicept
- Phase Of Trial
- Phase 3
- Exercise price
- 13.85
- New hires count
- 6
- Rsus granted shares
- 11350
- Options granted shares
- 53400
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.